NeuraMetrix, founded in 2013, is a Asheville, NC -based Medtech company whose mission is to support neurologists and psychiatrists with an accurate tool to detect and monitor various neurological diseases and psychiatric disorders and assess the efficacy of a particular treatment. In 2019, the U.S. Food and Drug Administration (FDA) granted Breakthrough Device designation to the NeuraMetrix Typing Cadence (TC) solution. Read more at www.neurametrix.com.